Organization
GANYMED Pharmaceuticals AG
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
GANYMED Pharmaceuticals AG
... ended March 31, 2017. "We achieved multiple milestones including the acquisition of Ganymed last December and an agreement with Ogeda shareholders to acquire Ogeda last ...
... news comes less than six months after Astellas announced it was buying Ganymed Pharmaceuticals, a German biopharmaceutical company, in a deal worth up to $1.4 ...
... "Astellas" ) today announced that it has completed the acquisition of Ganymed Pharmaceuticals AG ("Ganymed"), a biopharmaceutical company located in Mainz, Germany, and Ganymed has ...
... Care Act. ( Kaiser Health News ) 5. Astellas Pharma will acquire Ganymed Pharmaceuticals in a deal worth up $1.4 billion. Ganymed has a portfolio ...
... TARGET COMPANY: 1880339 Ganymed Pharmaceuticals AG SELLERS: 2403873 Seller Group - multiple shareholders ACQUIRER COMPANY: 2032909 Astellas ...
... on its cancer drug offerings. Tokyo-based Astellas announced plans Friday to acquire Ganymed Pharmaceuticals in a deal worth up to $1.4 billion. Astellas will pay ...
... a cancer drug deal Oct. 28. Astellas will acquire privately held Ganymed Pharmaceuticals AG for €422 million ($460.2 million) up front. Shareholders will be eligible ...
... Astellas Pharma Inc has agreed to acquire Ganymed Pharmaceuticals AG, a German biopharmaceutical company focused on developing antibodies against cancer. The ...
... Fountain Biopharma Inc., Fujifilm Corporation, Fusion Antibodies Limited, GamaMabs Pharma S.A., Ganymed Pharmaceuticals AG, Geistlich Pharma AG, Genelux Corporation, Genentech, Inc., Genisphere Inc., Genmab A/S, ...
... Ganymed Pharmaceuticals AG, a biopharmaceutical company developing highly targeted immunotherapies against cancer, announced outstanding ...
... AG Open New Research Headquarters in Mainz, Germany BioNTech AG and Ganymed Pharmaceuticals AG Open New Research Headquarters in Mainz, Germany. MAINZ, Germany, October 1, ...
... Venture Capital . FUNDED COMPANY: 1880339 Ganymed Pharmaceuticals AG REFERENCE DATE: November 18, 2013 FUNDED AMOUNT: 57.9 ROUND: Fifth INVESTORS: ...
... States Patent no. 8,529,904, issued on Sept. 10, was assigned to Ganymed Pharmaceuticals AG (Germany). "Immunotherapeutic methods using epitopes of WT-1 and GATA-1" was invented ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤